Lv11
30 积分 2025-01-14 加入
CS1003, a novel human and mouse cross-reactive PD-1 monoclonal antibody for cancer therapy
57分钟前
已完结
PD-L1 small-molecule modulators: A new hope in epigenetic-based multidrug cancer therapy?
1小时前
已完结
Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal
1个月前
已完结
The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity
1个月前
已完结
Leveraging non-enzymatic functions of LSD1 for novel therapeutics
2个月前
已完结
皖公网安备34019202002308
